258 related articles for article (PubMed ID: 32246545)
21. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
[TBL] [Abstract][Full Text] [Related]
22. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
23. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Implementation and Diagnostic Accuracy of the Paris Classification for Reporting Urinary Cytology in Voided Urine Specimens: A Cyto-Histological Correlation Study in a Cancer Center.
Lobo J; Lobo C; Leça L; Rodrigues Â; Henrique R; Monteiro P
Pathobiology; 2023; 90(4):233-240. PubMed ID: 36574757
[TBL] [Abstract][Full Text] [Related]
25. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
26. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
[TBL] [Abstract][Full Text] [Related]
27. Improved diagnostic precision of urine cytology by implementation of The Paris System and the use of cell blocks.
Chan E; Balassanian R; Tabatabai ZL; Lou H; Vohra P
Cancer Cytopathol; 2018 Sep; 126(9):809-816. PubMed ID: 30203925
[TBL] [Abstract][Full Text] [Related]
28. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
[TBL] [Abstract][Full Text] [Related]
29. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
[TBL] [Abstract][Full Text] [Related]
30. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
[TBL] [Abstract][Full Text] [Related]
31. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
Goutas D; Savvidou K; Vrettou K; Meletis E; Levis P; Constantinides C; Lazaris AC; Mikou P
Cytopathology; 2021 Nov; 32(6):795-801. PubMed ID: 34289188
[TBL] [Abstract][Full Text] [Related]
32. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
[TBL] [Abstract][Full Text] [Related]
33. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
34. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS
Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345
[TBL] [Abstract][Full Text] [Related]
35. Atypical urothelial cells classified according to the Paris System for Reporting Urinary Cytology: A 2-year experience with histological correlation from a Finnish tertiary care center-low rate and high risk of malignancy.
Pöyry E; Nykänen V; Pulkkinen J; Viljanen E; Laurila M; Kholová I
Cancer Cytopathol; 2023 Sep; 131(9):574-580. PubMed ID: 37246298
[TBL] [Abstract][Full Text] [Related]
36. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
[TBL] [Abstract][Full Text] [Related]
37. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
[TBL] [Abstract][Full Text] [Related]
38. Applying the Paris system for reporting urine cytology to challenging cytology cases.
Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
[TBL] [Abstract][Full Text] [Related]
39. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
[TBL] [Abstract][Full Text] [Related]
40. [A new terminology for urinary cytopathology: The Paris System for Reporting Urinary Cytology (2015)].
Courtade-Saïdi M; Cochand-Priollet B; Vielh P; Piaton E;
Ann Pathol; 2019 Sep; 39(5):344-351. PubMed ID: 31255415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
